MARKET

IART

IART

Integra Lifesciences Hldgs Cp
NASDAQ
29.54
+0.56
+1.92%
Opening 12:21 04/23 EDT
OPEN
29.05
PREV CLOSE
28.98
HIGH
29.59
LOW
28.97
VOLUME
269.75K
TURNOVER
0
52 WEEK HIGH
59.10
52 WEEK LOW
27.85
MARKET CAP
2.32B
P/E (TTM)
35.03
1D
5D
1M
3M
1Y
5Y
First Week of December 20th Options Trading For Integra LifeSciences Holdings (IART)
NASDAQ · 1d ago
Jefferies Sticks to Their Buy Rating for Integra Lifesciences (IART)
TipRanks · 1d ago
Weekly Report: what happened at IART last week (0415-0419)?
Weekly Report · 1d ago
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
Integra LifeSciences Holdings Corporation has rescheduled the release of the Company's first quarter 2024 financial results to May 6, 2024. The company's management team will host a conference call at 8:30 a.m. EDT. Integra is a leading global medical technology company.
Barchart · 5d ago
Weekly Report: what happened at IART last week (0408-0412)?
Weekly Report · 04/15 09:01
INTEGRA LIFESCIENCES HOLDINGS CORP <IART.O>: TRUIST SECURITIES CUTS TARGET PRICE TO $37 FROM $41
Reuters · 04/15 08:25
ClearBridge Small Cap Growth Strategy Q2 2024 Portfolio Manager Commentary
Seeking Alpha · 04/09 15:00
Here's Why Investors Should Retain Integra (IART) Stock Now
NASDAQ · 04/09 12:41
More
About IART
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.

Webull offers Integra Lifesciences Holdings Corp stock information, including NASDAQ: IART real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IART stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IART stock methods without spending real money on the virtual paper trading platform.